NB-APIXABAN DIN 02553643
Health Canada record
| Active ingredient(s) | APIXABAN 5 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | B01AF02 APIXABAN |
| Original market date | 05-Jun-2025 |
| Current status date | 05-Jun-2025 |
| Source | Health Canada DPD |
Establishment licence of the holder
NB Pharma Inc. — licence 3-002798, currently licensed, last inspection rating C (2025-12-05).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing APIXABAN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02487721 | ACH-APIXABAN | ACCORD HEALTHCARE INC | Tablet | APIXABAN 5 MG | Marketed |
| 02487713 | ACH-APIXABAN | ACCORD HEALTHCARE INC | Tablet | APIXABAN 2.5 MG | Marketed |
| 02529920 | AG-APIXABAN | ANGITA PHARMA INC. | Tablet | APIXABAN 5 MG | Marketed |
| 02529912 | AG-APIXABAN | ANGITA PHARMA INC. | Tablet | APIXABAN 2.5 MG | Marketed |
| 02548887 | APIXABAN | SANIS HEALTH INC | Tablet | APIXABAN 5 MG | Marketed |
| 02530716 | APIXABAN | SIVEM PHARMACEUTICALS ULC | Tablet | APIXABAN 5 MG | Marketed |
| 02530708 | APIXABAN | SIVEM PHARMACEUTICALS ULC | Tablet | APIXABAN 2.5 MG | Marketed |
| 02548879 | APIXABAN | SANIS HEALTH INC | Tablet | APIXABAN 2.5 MG | Marketed |
| 02487381 | APO-APIXABAN | APOTEX INC | Tablet | APIXABAN 2.5 MG | Marketed |
| 02487403 | APO-APIXABAN | APOTEX INC | Tablet | APIXABAN 5 MG | Marketed |
| 02486806 | AURO-APIXABAN | AURO PHARMA INC | Tablet | APIXABAN 2.5 MG | Marketed |
| 02486814 | AURO-APIXABAN | AURO PHARMA INC | Tablet | APIXABAN 5 MG | Marketed |
| 02527987 | BIO-APIXABAN | BIOMED PHARMA | Tablet | APIXABAN 5 MG | Marketed |
| 02527979 | BIO-APIXABAN | BIOMED PHARMA | Tablet | APIXABAN 2.5 MG | Marketed |
| 02397714 | ELIQUIS | BRISTOL-MYERS SQUIBB CANADA | Tablet | APIXABAN 5 MG | Marketed |
| 02377233 | ELIQUIS | BRISTOL-MYERS SQUIBB CANADA | Tablet | APIXABAN 2.5 MG | Marketed |
| 02528924 | JAMP APIXABAN | JAMP PHARMA CORPORATION | Tablet | APIXABAN 2.5 MG | Marketed |
| 02528932 | JAMP APIXABAN | JAMP PHARMA CORPORATION | Tablet | APIXABAN 5 MG | Marketed |
| 02529017 | M-APIXABAN | MANTRA PHARMA INC | Tablet | APIXABAN 5 MG | Marketed |
| 02529009 | M-APIXABAN | MANTRA PHARMA INC | Tablet | APIXABAN 2.5 MG | Marketed |
| 02492369 | MAR-APIXABAN | MARCAN PHARMACEUTICALS INC | Tablet | APIXABAN 2.5 MG | Marketed |
| 02492377 | MAR-APIXABAN | MARCAN PHARMACEUTICALS INC | Tablet | APIXABAN 5 MG | Marketed |
| 02495449 | MINT-APIXABAN | MINT PHARMACEUTICALS INC | Tablet | APIXABAN 5 MG | Marketed |
| 02495430 | MINT-APIXABAN | MINT PHARMACEUTICALS INC | Tablet | APIXABAN 2.5 MG | Marketed |
| 02492822 | NAT-APIXABAN | NATCO PHARMA (CANADA) INC | Tablet | APIXABAN 5 MG | Marketed |
| 02492814 | NAT-APIXABAN | NATCO PHARMA (CANADA) INC | Tablet | APIXABAN 2.5 MG | Marketed |
| 02553635 | NB-APIXABAN | NB PHARMA INC. | Tablet | APIXABAN 2.5 MG | Marketed |
| 02569191 | NB-APIXABAN TABLET | NB PHARMA INC. | Tablet | APIXABAN 5 MG | Approved |
| 02569183 | NB-APIXABAN TABLET | NB PHARMA INC. | Tablet | APIXABAN 2.5 MG | Approved |
| 02526069 | NRA-APIXABAN | NORA PHARMA INC | Tablet | APIXABAN 5 MG | Marketed |
| 02546892 | NRA-APIXABAN TABLETS | NORA PHARMA INC | Tablet | APIXABAN 5 MG | Marketed |
| 02546884 | NRA-APIXABAN TABLETS | NORA PHARMA INC | Tablet | APIXABAN 2.5 MG | Marketed |
| 02530732 | PRO-APIXABAN | PRO DOC LIMITEE | Tablet | APIXABAN 5 MG | Marketed |
| 02530724 | PRO-APIXABAN | PRO DOC LIMITEE | Tablet | APIXABAN 2.5 MG | Marketed |
| 02525518 | RIVA APIXABAN | LABORATOIRE RIVA INC. | Tablet | APIXABAN 2.5 MG | Marketed |
| 02525526 | RIVA APIXABAN | LABORATOIRE RIVA INC. | Tablet | APIXABAN 5 MG | Marketed |
| 02489236 | SANDOZ APIXABAN SDZ | SANDOZ CANADA INCORPORATED | Tablet | APIXABAN 5 MG | Marketed |
| 02489228 | SANDOZ APIXABAN SDZ | SANDOZ CANADA INCORPORATED | Tablet | APIXABAN 2.5 MG | Marketed |
| 02487519 | SANDOZ APIXABAN TABLET | SANDOZ CANADA INCORPORATED | Tablet | APIXABAN 2.5 MG | Marketed |
| 02487527 | SANDOZ APIXABAN TABLET | SANDOZ CANADA INCORPORATED | Tablet | APIXABAN 5 MG | Marketed |
| 02510464 | TARO-APIXABAN | SUN PHARMA CANADA INC | Tablet | APIXABAN 2.5 MG | Marketed |
| 02510472 | TARO-APIXABAN | SUN PHARMA CANADA INC | Tablet | APIXABAN 5 MG | Marketed |
| 02485001 | TEVA-APIXABAN | TEVA CANADA LIMITED | Tablet | APIXABAN 5 MG | Marketed |
| 02484994 | TEVA-APIXABAN | TEVA CANADA LIMITED | Tablet | APIXABAN 2.5 MG | Marketed |
| 02526050 | NRA-APIXABAN | NORA PHARMA INC | Tablet | APIXABAN 2.5 MG | Dormant |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 34472 | 2024-11-28 | Abbreviated New Drug Submission (ANDS) | Licensing Agreement between two manufacturers |
International API supply for APIXABAN
57 active FDA Drug Master Files.
Request a quote for NB-APIXABAN